Search results
The Michael J. Fox Foundation Applauds Passage of National Plan to End Parkinson's Act in Congress
WKRN Nashville· 18 hours agoNEW YORK, May 23, 2024 /PRNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) today celebrates the passage of ...
Newly discovered link between Parkinson's and IBD could lead to future treatment
MedicalNewsToday via AOL· 4 days agoAks Huckleberry/500px/Getty Images This article originally appeared on Medical News Today Previous ...
Head Transplant System Could Be Available In a Few Years
CCM· 1 hour agoThis groundbreaking procedure suggested by BrainBridge entails transferring the head of a healthy...
'Moving Forward': Battling Parkinson's, He's Rowing His Way to Paralympic Games
KLAX-TV· 1 day agoFor decades, Todd Vogt has been dedicated to the sport of rowing, believing he was in peak physical...
Moving Day Milwaukee hosted by the Parkinson's Foundation works to fight against Parkinson's disease
TMJ4 Milwaukee· 6 days agoThe Parkinson's Foundation held the 8th annual Moving Day Milwaukee today, May 18. Moving Day Milwaukee works to raise money for research
Researchers develop new light-controlled 'off switch' for brain cells
Medical Xpress· 2 hours agoResearchers from Duke-NUS Medical School have found that a new class of light-sensitive proteins are...
HC Wainwright Research Analysts Cut Earnings Estimates for Inhibikase Therapeutics, Inc. (NYSE:IKT)
ETF DAILY NEWS· 15 hours agoInhibikase Therapeutics, Inc. (NYSE:IKT – Free Report) – Research analysts at HC Wainwright lowered their Q2 2024 earnings estimates for Inhibikase Therapeutics in a
Motivated by lack of diversity in neurological studies, scientists look to ensure equity in brain ...
Medical Xpress· 4 days agoIn contrast, the scientists from the Lieber Institute for Brain Development...
Stuff in pomegranates can ease Alzheimer's symptoms
Futurity· 2 hours agoA substance naturally occurring in pomegranates, strawberries, and walnuts can improve memory and treatment of Alzheimer’s disease, a new study in mice...
IRLAB has Administered the First Dose in a Phase I Clinical Trial with the Drug Candidate IRL757
Digital Journal· 2 days ago(FRA:6IRA) Gothenburg, Sweden, May 22, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson'